Definitive Healthcare Corp. (DH) – What Are Brokerages Thinking About This Stock?

Definitive Healthcare Corp. (NASDAQ:DH) has received a consensus rating of “Reduce” from the ten research firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $1.47.

DH has been the subject of a number of recent research reports. Bank of America restated an “underperform” rating and issued a $0.70 target price on shares of Definitive Healthcare in a research note on Monday, June 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Definitive Healthcare in a research report on Monday, August 31st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $1.00 price target on shares of Definitive Healthcare in a research note on Wednesday, August 12th. Morgan Stanley decreased their price target on shares of Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Finally, Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Sunday, September 13th.

Definitive Healthcare Trading Up 0.4%

Shares of DH opened at $0.99 on Friday. The stock’s 50-day moving average price is $0.89 and its 200 day moving average price is $0.88. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $105.19 million, a price-to-earnings ratio of 24.53, a P/E/G ratio of 12.11 and a beta of 1.40. Definitive Healthcare has a 12-month low of $0.61 and a 12-month high of $3.12.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. Definitive Healthcare had a positive return on equity of 3.55% and a negative net margin of 72.28%. The company had revenue of $55.20 million during the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. As a group, research analysts predict that Definitive Healthcare will post 0.06 earnings per share for the current year.

Institutional Trading of Definitive Healthcare

Several institutional investors have recently made changes to their positions in the business. Corient Private Wealth LP bought a new stake in Definitive Healthcare in the second quarter valued at about $378,000. Squarepoint Ops LLC raised its position in Definitive Healthcare by 46.5% in the second quarter. Squarepoint Ops LLC now owns 351,575 shares of the company’s stock worth $292,000 after purchasing an additional 111,634 shares in the last quarter. Flywheel Private Wealth LLC acquired a new position in Definitive Healthcare in the first quarter worth about $83,000. Irenic Capital Management LP bought a new position in Definitive Healthcare during the first quarter worth about $71,000. Finally, Williams & Novak LLC lifted its stake in Definitive Healthcare by 155.8% during the second quarter. Williams & Novak LLC now owns 78,610 shares of the company’s stock worth $65,000 after purchasing an additional 47,880 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp. is a healthcare commercial intelligence company that provides data, analytics and software to help organizations understand the healthcare market. Its platform is designed to support decision-making across areas such as sales and marketing, market access, provider network strategy, competitive intelligence and healthcare operations.

The company’s products combine information on healthcare providers, hospitals, health systems, medical groups, payers, procedures and related market activity.